Drug Delivery
Drug delivery systems include inhalers, injectors and infusion pumps; it is a sector of the pharmaceutical industry with tremendous growth prospects.
Browse Research and Markets’ Drug Delivery category to explore all aspects of this technology-driven industry, whether according to method of delivery (e.g. oral, intranasal, transdermal), affliction (e.g. diabetes, allergies, inflammation), or specific areas such as paediatric drug delivery, self-administration and drug safety.
Our
... more
Sort by
-
Drug Delivery Media Monitor
Moreover Technologies, May 2013About the service: When drug delivery technology news breaks, we get it fast—so you can deliver fresh business intelligence - Search 33,500 news sources - Plus, search 508,000 social media sources -... -
Transdermal Drug Delivery - Technologies, Markets, and Companies
Jain PharmaBiotech, May 2013 , Pages: 280This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes... -
Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017
Markets and Markets, Apr 2013 , Pages: 316The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal... -
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics– Forecasts to 2017
Markets and Markets, Apr 2013 , Pages: 280The North American injectable drug delivery technologies market was valued at $9 3 billion in 2012; it is expected to reach $16 6 billion by 2017 at a CAGR of 12 3% from 2012 to 2017 Injectable drug... -
Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017
Markets and Markets, Apr 2013 , Pages: 368The global injectable drug delivery technologies market was valued at $22 5 billion in 2012, and is expected to reach $43 3 billion by 2017 at a CAGR of 14 0% from 2012 to 2017 Injectable drug delivery... -
Early Stage Drug Delivery Technologies: Profiles of Start-ups and Emerging Companies
MCD Group LLC, Apr 2013 , Pages: 132MCD Group continuously researches and monitors emerging drug delivery technologies and has compiled this report to profile some of the innovative developments at younger, emerging companies The report... -
Inhaler Devices: Fundamentals, Design and Drug Delivery
Woodhead Publishing Ltd, Apr 2013 , Pages: 192Given their direct impact on the health and quality of life for millions, inhalers represent a major turning point in the history of modern medicine Inhaler devices: Fundamentals, design and drug delivery... -
Drug Delivery: Surveying the Global Competitive Landscape
Espicom Business Intelligence Ltd, Mar 2013 , Pages: 702Drug Delivery: Surveying the global competitive landscape is a richly-detailed report which examines, in depth, 106 leading and emerging specialist drug delivery companies The report covers all major... -
Implantable Drug Delivery Devices (Contraceptives, Drug Infusion Pumps, Intraocular Implants, Drug Eluting, Bio-Absorbable Stents, Biodegradable) Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
Transparency Market Research, Mar 2013 , Pages: 104The global implantable drug delivery devices hold a competitive edge over other drugs and devices owing to the fact that they are implanted at targeted sites and so deliver unaltered amounts of drugs... -
Transdermal Drug Patches to 2018 Products, Indications, Markets and Forecasts
Greystone Associates, Mar 2013Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver Advances in synthetic materials... -
Pen Injectors Devices, Drugs, Combination Products
Greystone Associates, Mar 2013User-friendly designs and the availability of an increasing number of drugs in pre-filled disposable cartridges and syringes are propelling the growth of injector pens at the expense of other drug delivery... -
Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect
Greystone Associates, Mar 2013While autoinjectors are sometimes designed to work with a particular injectable product as a form of pharmaceutical branding, the typical autoinjector is designed to fit one or more standard sizes of... -
Drug Self-Administration to 2018 Drug Products, Indications, Markets and Forecasts
Greystone Associates, Mar 2013While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally Because they cannot tolerate the first-pass metabolism of... -
Prefilled Syringes to 2018 Devices, Drugs, Markets, Players and Prospects
Greystone Associates, Mar 2013The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being Now this segment is evolving in response to changing... -
Injectable Drug Delivery to 2018 Drugs, Devices, Targets, Therapeutics and Forecasts
Greystone Associates, Feb 2013The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them This shift has fostered change on several... -
Advanced Devices for Injectable Drugs. Products, Players and Prospects
Greystone Associates, Jan 2013The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them This shift has fostered change on several... -
Closed Drug Transfer Systems. Therapeutic Markets, Strategies and Outlook
Greystone Associates, Jan 2013The administration of drugs deemed hazardous to humans has been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more clearly understood For caregivers... -
The Top 100 Drug Delivery Technology Companies Worldwide (2013)
Research Facts Ltd, Jan 2013The Top 100 Drug Delivery Technology Companies Worldwide (2013) "The Top 100 Drug Delivery Technology Companies Worldwide (2013)" is perfect for those companies who wish to identify and make contact... -
Point-of-Delivery Drug. Reconstitution Systems Markets, Strategies and Prospects
Greystone Associates, Jan 2013Growth in the number of injectable drugs supplied in solid form for reconstitution prior to administration is being driven by the increase in drugs based on biological NCEs These drugs are typically... -
Intelligent Drug-Delivery Platforms
Future Science Ltd, Dec 2012 , Pages: 124Therapeutic Delivery December 2012 is a special focus on intelligent drug delivery systems, guest edited by Dr Paul C Ho (National University of Singapore, Singapore) and Dr Kit S Lam (University of... -
Research Report on China's Hypolipidemic Drug Market, 2012-2013
China Research & Intelligence, Nov 2012 , Pages: 55As the population further aging in China, the proportion of diseases such as hypertension caused by hyperlipidemia in cardiovascular diseases of the elderly presents an increasing trend year by year... -
United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery - Volume 2: Patient Perspectives
Frost & Sullivan, Nov 2012 , Pages: 103Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry In Oncology, developers are interested in understanding the opportunities and parameters for delivery... -
Chinese Markets for Drug Delivery System
AMID Co, Nov 2012 , Pages: 211China's demand for drug delivery system has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic... -
Nanoparticulate drug delivery: Perspectives on the transition from laboratory to market
Woodhead Publishing Ltd, Oct 2012 , Pages: 250Nanoparticulate drug delivery highlights and examines the transition of nanoparticulate drug delivery systems, operating at scales of billionths of a metre, from laboratory into a commercially viable... -
IV Fluid Transfer Devices Products, Players, Markets and Opportunities
Greystone Associates, Oct 2012Intravenous drug administration is one of the most common therapeutic procedures that patients in a hospital setting are likely to receive Yet the lack of standardization among the various components,... -
2009 United States Oncology Drug Delivery Patterns, Preferences, and Opportunities - Volume 1: Oncologist and Infusion Nurse Perspectives
Frost & Sullivan, Sep 2012 , Pages: 97Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry This customer research was completed to understand trends, dynamics, and parameters specific to... -
Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance
GBI Research, Sep 2012 , Pages: 69GBI Research, the leading business intelligence provider, has released its latest research, “Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency... -
Microneedle Drug Delivery Patches, Syringes & Systems - Devices, Players, Markets and Forecasts
Greystone Associates, Sep 2012Microneedle technology is attaining commercial viability at a time when drug developers are faced with new challenges as they assess ways to administer new classes of compounds with significant therapeutic... -
09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities
Life Science Intelligence, Sep 2012This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in September 2012 All companies include technology, market(s), key... -
Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management
GBI Research, Aug 2012 , Pages: 56Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management Summary GBI Research, leading business intelligence provider has released its latest research... -
Optimization of Comparative Efficacy Trials
Scripp Business Insights, Aug 2012 , Pages: 31Clinicians and patients want to be able to compare new drugs with those already available to inform evidence-based medicine, and reimbursement authorities require comparative data to support their decisions... -
2012 China Sodium Hyaluronate Injection Development Forecast Report
QYresearch, Aug 2012 , Pages: 121This 2012 China Sodium Hyaluronate Injection Development Forecast Report is a professional and in-depth research report on the China Sodium Hyaluronate Injection industry The report firstly discusses... -
U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery
iData Research, Jul 2012 , Pages: 270The U S market for diabetes diagnosis, treatment and drug delivery is expected to exceed $17 87 billion by 2018 The market segments covered in this report include: - traditional blood glucose meters,... -
U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery (Executive Summary)
iData Research, Jul 2012The U S market for diabetes diagnosis, treatment and drug delivery is expected to exceed $17 87 billion by 2018 The market segments covered in this report include: - traditional blood glucose meters,... -
Needle-Free Drug Injection Systems and Safety Syringes - Global Strategic Business Report
Global Industry Analysts, Inc, Jul 2012 , Pages: 504This report analyzes the worldwide markets for Needle-Free Drug Injection Systems and Safety Syringes in US$ Million The report provides separate comprehensive analytics for the US, Canada, Japan, Europe,... -
Oral Transmucosal Drug Delivery. Products, Players, Markets & Forecasts
Greystone Associates, Jun 2012In their search for alternative delivery methods that will enhance compliance and improve safety, drug developers and researchers are discovering that the permeability of mucous membranes provides a... -
Product Strategies for Non-Oral Hematology Drugs
Greystone Associates, Jun 2012The administration of non-oral drugs for the treatment of blood disorders has evolved over the past ten years to include heparin analogs and recombinant proteins designed to treat chronic conditions... -
06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities
Life Science Intelligence, Jun 2012 , Pages: 40This report includes details on 39 emerging medical technology companies that have been identified by LSI's in-house research team in June 2012 All companies include technology, market(s), key executive,... -
Innovations in the Delivery of Peptides
Scripp Business Insights, May 2012 , Pages: 241The number of therapeutic peptides in clinical study is on the rise, but most are inherently unsuited to simple oral delivery The success of such drugs will depend to a large extent on the application... -
Diabetes Landscape: Market, Technology and Intellectual Property
Espicom Business Intelligence Ltd, May 2012 , Pages: 562In November 2011, the International Diabetes Federation (IDF) released data showing that the number of people living with diabetes globally had reached 366 million The IDF estimates that the number... -
Integrated Safety Syringes to 2016: Devices, Markets Players and Prospects
Greystone Associates, May 2012Safety syringe products encompass a broad range of design approaches including manual and automatic needle retraction, sliding needle sheath and auto disabling devices Safety syringes address the caregiver... -
Intranasal Drug Delivery - Global Business Strategic Report
Global Industry Analysts, Inc, May 2012 , Pages: 441This report analyzes the US market for Intranasal Drug Delivery in US$ Million by the following Therapeutic Areas: Allergic Infections, Analgesics, Osteoporosis, and Vaccinations. Annual estimates and... -
05 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities
Life Science Intelligence, May 2012 , Pages: 45This report includes details on 41 emerging medical technology companies that have been identified by LSI's in-house research team in May 2012 All companies include technology, market(s), key executive,... -
Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities
Greystone Associates, May 2012As a group, autoimmune diseases represent one of the most intractable families of conditions facing medical science The complexities and genetic underpinnings of the human immune response result in... -
Patch Pump Drug Delivery Systems. Devices, Markets, Players and Prospects
Greystone Associates, May 2012Patch pumps are the convergence of several technologies into a single drug delivery device package In doing so, this class of devices overcomes a number of shortcomings and limitations, while simplifying... -
Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth
GBI Research, Apr 2012 , Pages: 68GBI Research, the leading business intelligence provider, has released its latest research “Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small... -
04- 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities
Life Science Intelligence, Apr 2012 , Pages: 38This report includes details on 37 emerging medical technology companies that have been identified by LSI's in-house research team in April 2012 All companies include technology, market(s), key executive,... -
Special Purpose Needles - Global Strategic Business Report
Global Industry Analysts, Inc, Mar 2012 , Pages: 569This report analyzes the worldwide markets for Special Purpose Needles in US$ Million by the following Product Segments: Acupuncture Needles, Aspirating Needles, Biopsy Needles, Blood Collection Needles,... -
03 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities
Life Science Intelligence, Mar 2012 , Pages: 81This report includes details on 61 emerging medical technology companies that have been identified by LSI's in-house research team in March 2012 All companies include technology, market(s), key executive,... -
Needle Array Drug Delivery Systems: Devices, Therapeutic Markets, Strategies and Prospects
Greystone Associates, Feb 2012Evolution in drug delivery device design is changing the way a growing number of therapeutic substances are administered This trend is being fostered by the desire by patients for more user friendly...
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
